ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (CLPT)
CUSIP: 18507C103
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, $0.01 par value per share
- Shares outstanding
- 30,182,365
- Total 13F shares
- 1,142,056
- Share change
- -136,344
- Total reported value
- $4,063,000
- Price per share
- $3.56
- Number of holders
- 24
- Value change
- -$489,528
- Number of buys
- 4
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 18507C103?
CUSIP 18507C103 identifies CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 18507C103:
Top shareholders of CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
455,038
|
$1,629,000 | — | 31 Mar 2020 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.5%
|
151,584
|
$543,000 | — | 31 Mar 2020 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.45%
|
136,525
|
$489,000 | — | 31 Mar 2020 | |
| Merriman Wealth Management, LLC |
13F
|
Company |
0.32%
|
96,700
|
$346,000 | — | 31 Mar 2020 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.27%
|
80,911
|
$290,000 | — | 31 Mar 2020 | |
| KIRR MARBACH & CO LLC /IN/ |
13F
|
Company |
0.14%
|
42,200
|
$218,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
53,361
|
$191,000 | — | 31 Mar 2020 | |
| Mayo Clinic |
13F
|
Company |
0.16%
|
47,148
|
$169,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
28,300
|
$101,000 | — | 31 Mar 2020 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.09%
|
28,000
|
$100,000 | — | 31 Mar 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.08%
|
25,078
|
$90,000 | — | 31 Mar 2020 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.08%
|
23,700
|
$85,000 | — | 31 Mar 2020 | |
| Williams Jones Wealth Management, LLC. |
13F
|
Company |
0.07%
|
21,552
|
$77,000 | — | 31 Mar 2020 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.07%
|
20,000
|
$72,000 | — | 31 Mar 2020 | |
| WESTWOOD MANAGEMENT CORP /IL/ |
13F
|
Company |
0.06%
|
17,500
|
$63,000 | — | 31 Mar 2020 | |
| REGIONS FINANCIAL CORP |
13F
|
Company |
0.04%
|
11,655
|
$42,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
11,053
|
$40,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
10,849
|
$38,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
8,343
|
$30,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
3,250
|
$12,000 | — | 31 Mar 2020 | |
| Moisand Fitzgerald Tamayo, LLC |
13F
|
Company |
0.01%
|
2,216
|
$8,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,500
|
$5,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Mar 2020 | |
| OPTIMUM INVESTMENT ADVISORS |
13F
|
Company |
0%
|
437
|
$2,000 | — | 31 Mar 2020 |
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (CLPT) as of Q2 2020
As of 30 Jun 2020,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (CLPT) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,142,056 shares.
The largest 10 holders included
VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, Worth Venture Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Merriman Wealth Management, LLC, Mayo Clinic, MILLENNIUM MANAGEMENT LLC, KIRR MARBACH & CO LLC /IN/, and BROWN ADVISORY INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
25
Q2 2020 holders
24
Holder diff
-1
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.